PHIA Koninklijke Philips N.V.

KLM and Philips to set up a special freight airlift from Amsterdam to China

KLM and Philips to set up a special freight airlift from Amsterdam to China

April 9, 2020 

Special airlift complements existing airlift between Amsterdam and the US

Amsterdam, the Netherlands - With the current loss of around 90% of all flights between Europe and Asia, there is a major shortage of freight capacity. At the same time, and precisely because of the crisis surrounding COVID-19, there is a huge requirement to transport medical equipment and other supplies quickly between the US, Europe and China. KLM has now joined forces with (NYSE: PHG; AEX: PHIA) and the Dutch government to create a temporary special cargo airlift between the Netherlands and China. In addition to these parties, requests for extra capacity are coming from many other organizations. This airlift to Asia will start on April 13, 2020.

During the coming six to eight weeks, specifically for this important airlift between the Netherlands and China, KLM will bring its Boeing 747 Combi aircraft back into operation, ensuring a continuous flow of special freight capacity – two times a week to Beijing and three times a week to Shanghai. This will create approximately 250 tons of extra freight capacity in each direction per week. The flights will operate alongside the existing services of the so-called skeleton timetable that has been in force since March 29, 2020 with two Beijing and two Shanghai flights operated using Boeing 787s and Boeing 777s.

The Full Freighters of KLM/Martinair will continue to be deployed on North Atlantic routes, which Philips will use to airlift from Amsterdam to distribution points in the US. KLM/Martinair will also continue to fly on South Atlantic routes as well as to Africa.

In view of the current 90% decline in flights and future expectations, KLM had decided in early March 2020 to phase out its remaining Boeing 747s as of April 2020 instead of summer 2021. For the airlift from Amsterdam to Shanghai and Beijing, two Boeing 747 Combi aircraft are now being put back into service specifically for these two routes and for the indicated period.

“I consider it extremely important that especially in this time of crisis, KLM can add value to Dutch society through flexibility, creativity and collaboration,” said Pieter Elbers, President and CEO of KLM. “Philips’ initiative to team up with KLM to find a solution for the pressing need for freight capacity between Europe and China for critical medical equipment and supplies fully underlines this. I am proud that a joint team of very committed and professional colleagues from both companies have been able to create an adequate solution in such a short time frame.”

“Philips and KLM have been important partners for more than a hundred years,” said Frans van Houten, CEO Royal Philips. “It is good that we have quickly found each other again in this time of need to make this important airlift to China possible. In combination with the existing airlift to the US, we can now transport essential medical products and supplies faster between the US, Europe and China, helping healthcare providers more quickly in their difficult task of fighting the coronavirus.”

For further information, please contact:

Steve Klink

Philips Global Press Office

Tel.:

E-mail:

Leandro Mazzoni

Philips Investor Relations

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at .



Attachments

EN
09/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new...

MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member April 2, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Carla Goulart Peron, MD, Chief Medical Officer at Philips, has been appointed to the of the Medical Device Innovation Consortium (). Founded in 2012, MDIC is a unique public-private partnership that brings stakeholders across the medical device spectrum together with the US Food and Drug Administration () and other agency partners to help ensure patient access to medical device inn...

 PRESS RELEASE

FDA clears Philips AI solution that provides real-time guidance during...

FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair March 26, 2026 Philips DeviceGuide uses AI to track and visualize mitral valve repair devices [1] in real time during minimally invasive procedures, supporting treatment [2]DeviceGuide integrates with Philips Azurion image-guided therapy platform that combines imaging, real-time data and intelligent software within a unified workflow to support more consistent, efficient and confidently guided minimally invasive procedures Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA...

 PRESS RELEASE

Philips launches IntraSight Plus to simplify coronary interventions an...

Philips launches IntraSight Plus to simplify coronary interventions and advance precision care March 25, 2026 Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient careWith FDA clearance and CE marking, IntraSight Plus streamlines the workflow efficiency of minimally invasive coronary procedures and can enable system operation time savings up to 47% in both the USA and Europe Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technolog...

 PRESS RELEASE

Philips remains No. 1 in Medtech at European Patent Office and the lar...

Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant March 24, 2026 Philips ranks No. 1 among medical technology companies in the European Patent Office Technology Dashboard 2025, filing 1,289 patent applications with the EPO in 2025.Philips’ platform-based solutions integrate hardware, software, data and AI to address clinical, operational and everyday health challenges.Philips’ innovation improved the lives of 2 billion people in 2025, with the goal of improving 2.5 billion lives per year by 2030, including 400 million people in medically unde...

 PRESS RELEASE

Philips convenes the Annual General Meeting of Shareholders 2026

Philips convenes the Annual General Meeting of Shareholders 2026 March 23, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposal to appoint John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026.Proposals to re-appoint Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as m...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch